Beta Thalassemia pipeline drugs
Jan 21, 2022
Beta Thalassemia Treatment – Insights Into the Challenges & Solutions
Beta Thalassemia (β-Thalassemia) is a blood disorder characterized by reduced synthesis of the hemoglobin subunit beta (hemoglobin beta chain) that results in microcytic hypochromic anemia, an abnormal peripheral blood smear with nucleated red blood cells, and reduced amounts of hemoglobin A (HbA) on hemoglobin ana...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
